Strategy to Improve Genotoxic Chemotherapy using the Rev1 C-Terminal Domain
Invention type: Technology
/
Case number: #26149
Researchers
Departments: Department of Biology
Technology Areas: Drug Discovery and Research Tools: Genomics & Proteomics / Therapeutics: Nucleic Acids, Proteins & Antibodies, Small Molecules
Impact Areas: Healthy Living
-
improving dna damaging chemotherapy using the rev1 cterminal domain (ctd)
United States of America | Pending
License this technology
Interested in this technology? Connect with our experienced licensing team to initiate the process.
Sign up for technology updates
Sign up now to receive the latest updates on cutting-edge technologies and innovations.